◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

YUBO INTERNATIONAL BIOTECH LTD

CIK: 895464 SIC: 3845
$-18.00
Revenue
$-1.33M
Net Income
-
Gross Margin
-
Op. Margin
$-2.39M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 6 of 44 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue - - - $-18.00 - -
Revenue Growth % (YoY) nan% nan% nan% nan% nan% nan%
Cost of Revenue - - - $-5.00 - -
+ Gross Profit - - - $-13.00 - -
Gross Margin % nan% nan% nan% 72.2% nan% nan%
Operating Expenses $310.13K $249.70K $467.30K $357.29K $532.76K $470.44K
+ Operating Income $-310.13K $-249.70K $-467.30K $-357.30K $-532.76K $-470.44K
Operating Margin % nan% nan% nan% 1984988.9% nan% nan%
Interest Expense $18.00 $23.00 - - $49.00 $17.00
Other Income/Expense $-18.00 $-23.00 $-19.00 $4.41K $-88.29K $-127.91K
Income Before Tax $-310.15K $-249.72K $-467.32K $-352.89K $-621.05K $-598.35K
Income Tax Expense - - - - - -
+ Net Income $-310.15K $-230.33K $-435.63K $-352.89K $-621.05K $-598.35K
Net Margin % nan% nan% nan% 1960477.8% nan% nan%
Diluted EPS 0.00 0.00 0.00 -0.01 -0.01 nan
Diluted Shares Outstanding 147.9M 119.8M 119.8M - 119.8M -
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Accounts Receivable $114.29K $118.01K $146.69K $164.98K $218.01K $210.59K
Inventory $37.89K $37.65K $37.21K $36.95K $6.57K $86.85K
Total Current Assets $649.56K $659.10K $685.16K $682.75K $723.97K $761.40K
Property Plant & Equipment $84.64K $126.01K $165.95K $205.91K $256.78K $293.25K
Intangible Assets $43.24K $44.65K $47.51K $50.52K $56.07K $57.49K
Total Assets $953.21K $1.05M $1.17M $1.53M $1.65M $1.73M
Total Current Liabilities $2.56M $5.03M $4.78M $4.72M $4.49M $3.95M
Total Liabilities $2.56M $5.03M $4.81M $4.83M $4.70M $4.15M
Retained Earnings $-7.48M $-7.33M $-7.10M $-6.66M $-6.37M $-5.79M
Total Stockholders Equity $-1.66M $-4.00M $-3.67M $-3.42M $-3.13M $-2.52M
Total Liabilities & Equity $953.21K $1.05M $1.17M $1.53M $1.65M $1.73M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-310.15K $-230.33K $-435.63K $-352.89K $-621.05K $-598.35K
Depreciation & Amortization $41.89K $83.01K $41.26K $39.17K $130.71K $84.71K
Change in Receivables - - $-18.30K $-53.03K $138.36K $130.94K
Change in Inventory - - $259.00 $-185.85K $8.23K $172.00
Operating Cash Flow $-714.05K $-354.99K $-392.05K $-932.71K $-405.02K $-312.40K
Capital Expenditure - - $6.19K - - -
Investing Cash Flow $79.90K $79.90K $-6.19K - $118.43K $81.96K
Financing Cash Flow $473.92K $473.92K $277.78K $1.11M $297.76K $272.38K
Net Change in Cash $3.91K $3.40K $2.76K $-1.02K $1.68K $1.34K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - - $3.49K
Cost of Revenue - - - $827.00
Gross Profit - - - $2.66K
Operating Expenses $310.13K $532.76K $902.23K $1.42M
Operating Income $-310.13K $-532.76K $-902.23K $-1.41M
Interest Expense $18.00 $49.00 $60.00 $52.00
Other Income/Expense $-18.00 $-88.29K $-60.00 $-216.28K
Income Before Tax $-310.15K $-621.05K $-902.29K $-1.63M
Income Tax Expense - - - -
Net Income $-310.15K $-621.05K $-902.29K $-1.63M
Diluted EPS 0.00 -0.01 -0.01 -0.01
Diluted Shares Outstanding $147.87M $119.82M $129.27M $119.82M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Accounts Receivable $114.29K $164.98K
Inventory $37.89K $36.95K
Total Current Assets $649.56K $682.75K
Property Plant & Equipment $84.64K $205.91K
Intangible Assets $43.24K $50.52K
Total Assets $953.21K $1.53M
Total Current Liabilities $2.56M $4.72M
Total Liabilities $2.56M $4.83M
Retained Earnings $-7.48M $-6.66M
Total Stockholders Equity $-1.66M $-3.42M
Total Liabilities & Equity $953.21K $1.53M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-310.15K $-621.05K $-902.29K $-1.63M
Depreciation & Amortization $41.89K $45.99K $124.90K $130.71K
Operating Cash Flow - - $-714.05K $-405.02K
Investing Cash Flow - - $79.90K $118.43K
Financing Cash Flow - - $473.92K $297.76K
Net Change in Cash - - $3.91K $1.68K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...